Wednesday, March 4, 2026

Latest
Green Canada Locks Marshall Uranium Deal As MAACKK Reverse Takeover Nears
Churchill Port Signs Antwerp-Bruges Partnership For Trade, Pushes For New Cargo Routes
Revival Gold Reports 4.2 g/t Over 25 Meters At Mercur
George Weston Sees Q4 2025 Profit Drop Despite Sales Growth
Gas Shutoffs Cascade as US-Israel Strikes on Iran Spark Energy Crisis
SSR Mining To Sell Çöpler Mine Stake For $1.5B Cash
Bay du Nord Deal Reopens $14B Newfoundland Offshore Project
Canadian Gold Hits 19.5 g/t Gold Over 1.0 Metre At Lac Arsenault
Trump Vows to Cut Off Spain Over Base Access Refusal—But Can He?
Canada Deploys $3.6 Billion to Accelerate Critical Minerals Development
Search

Kalytera Therapeutics share structure as of November 28, 2017.

Kalytera Therapeutics share structure as of November 28, 2017.

Kalytera Therapeutics share structure as of November 28, 2017.

© 2026
the deep dive
Welcome to The Deep Dive, where we focus on providing investors of Canadian junior stock markets the knowledge they need to make smart investment decisions. We take a closer look at all data relating to organizations to create quality stock analysis for investors. Not a recommendation to buy or sell securities. Always do additional research and consult a professional before purchasing a security.